Showing results (81-90 of 102) with videos related to
Sort By:
Pageof 11
ESC Heart Failure|August 1, 2025
Diagnostic value of computed tomography-based muscle quality and metabolic signatures in heart failure with sarcopeniaWataru Kawaharata, Hidemichi Kouzu, Keishi Ogura, et al.Plos One|November 27, 2013
Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general populationShutaro Ishimura, Masato Furuhashi, Yuki Watanabe, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 7, 2024
Metabolic dysfunction-associated steatotic liver disease (SLD) and alcohol-associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10-year follow-up periodKazuma Mori, Marenao Tanaka, Tatsuya Sato, et al.Scientific Reports|March 18, 2017
Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophagesMasato Furuhashi, Masatsune Ogura, Megumi Matsumoto, et al.The American Journal of Cardiology|September 3, 2021
Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without MedicationMasato Furuhashi, Atsuko Muranaka, Satoshi Yuda, et al.Clinical and Experimental Nephrology|July 12, 2021
Seasonal variation of serum 25-hydroxyvitamin D level in hemodialysis patients in the northernmost island of JapanYufu Gocho, Marenao Tanaka, Hirohito Sugawara, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 26, 2026
Exploring a Subpopulation of MASLD Associated With New Onset of CKD Using Supervised Clustering TechniquesItaru Hosaka, Marenao Tanaka, Tatsuya Sato, et al.Journal of Diabetes and Its Complications|August 6, 2025
The health stage of cardiovascular-kidney-metabolic (CKM) syndrome is useful for predicting all-cause mortality in patients with type 2 diabetes: a cohort study in a period prior to the standard use of recent pharmacotherapyKeitaro Nishizawa, Marenao Tanaka, Tatsuya Sato, et al.Clinical and Experimental Nephrology|November 18, 2020
Impact of atrial fibrillation on the risk of ischemic stroke in patients on hemodialysis: BOREAS-HD3 StudyAyumu Kimura, Marenao Tanaka, Norihito Moniwa, et al.Journal of the American Heart Association|January 15, 2019
Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary ArteryRyosuke Numaguchi, Masato Furuhashi, Megumi Matsumoto, et al.Pageof 11